Masimo is back in court defending its blood oxygen patent, this time it’s taking on the U.S. government, alleging it’s allowing Apple to infringe.
Following a decision that offered Apple a way to bring its Apple Watch blood oxygen tool back in the U.S., Bloomberg reports that Masimo alleges U.S. Customs and Border Protection « unlawfully let Apple Inc. reactivate a blood-oxygen tracking feature on Apple Watches that infringes patents for the technology », according to a suit filed in federal court.
With that, Masimo wants a temporary restraining order and preliminary injunction from the court to halt Apple’s blood oxygen feature on its Apple Watch Series 9, Apple Watch Series 10, and Apple Watch Ultra 2 models.
